|Articles|October 1, 2001

October 2001
Volume 7
Issue 10

Diagnostic, Prognostic, and Cost Assessment of Coronary Artery Disease in Women

Author(s)C. Noel Bairey Merz, MD, B. Delia Johnson, PhD, Sheryl F. Kelsey, PhD

Download PDF: Diagnostic, Prognostic, and Cost Assessment of Coronary Artery Disease in Women

Articles in this issue

almost 25 years ago

Article

Medical and Surgical Management of Coronary Artery Disease in Women

almost 25 years ago

Article

A Pharmacy-Based Approach to Cholesterol Management

almost 25 years ago

Article

Cost Implications of Introducing an Alternative Treatment for Patients with Osteoarthritis of the Knee in a Managed Care Setting

almost 25 years ago

Article

Can Health Systems Heal Themselves?

almost 25 years ago

Article

Chronic Pelvic Pain in Women

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Diagnostic, Prognostic, and Cost Assessment of Coronary Artery Disease in Women

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

Diagnosing Alzheimer's Disease Agitation: Triggers, Care Specialties, and the Role of Primary Care

Defining Alzheimer's Disease Agitation: Diagnostic Criteria, Symptoms, and Disease Course

Nipocalimab Improves gMG Outcomes Across East Asian Subgroup

Contributor: State Leaders Need Real-World Evidence to Integrate Social Care at Scale

FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis